About Pharmaceutics International
Pharmaceutics International is a company based in Hunt Valley (United States) founded in 1994 was acquired by Jabil in February 2025. Pharmaceutics International has raised $171.23 million across 12 funding rounds from investors including Jabil, PharmaScience and Signet Healthcare Partners. Pharmaceutics International offers products and services including Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing. Pharmaceutics International operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Hunt Valley, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmaceutics International, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharmaceutics International
Pharmaceutics International offers a comprehensive portfolio of products and services, including Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing.
Provides reliable testing for drug quality and compliance.
Develops stable formulations for various pharmaceutical products.
Handles aseptic fill-finish for injectable drug manufacturing.
Produces tablets, capsules, and liquids for oral medications.
People of Pharmaceutics International
Unlock access to complete
Unlock access to complete
Funding Insights of Pharmaceutics International
Pharmaceutics International has successfully raised a total of $171.23M across 12 strategic funding rounds. The most recent funding activity was a Unspecified round of $11.25 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pharmaceutics International
Pharmaceutics International has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Jabil, PharmaScience and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Locked | Locked | Locked | |
|
Global private equity investments are managed by the firm.
|
Locked | Locked | Locked | |
|
Hildred is focused on private equity investments in healthcare.
|
Locked | Locked | Locked |
Investor details for Pharmaceutics International
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmaceutics International
Investment portfolio details for Pharmaceutics International
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharmaceutics International
Detailed financials for Pharmaceutics International
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmaceutics International Comparisons
Peer comparison for Pharmaceutics International
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharmaceutics International
Pharmaceutics International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Pharmaceutics International
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmaceutics International
Complete news archive for Pharmaceutics International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmaceutics International
Pharmaceutics International was founded in 1994 and raised its 1st funding round 22 years after it was founded.
Pharmaceutics International is headquartered in Hunt Valley, United States. It is registered at Hunt Valley, Maryland, United States.
Pharmaceutics International is a funded company, having raised a total of $171.23M across 12 funding rounds to date.
Pharmaceutics International was founded in 1994 and is located in Hunt Valley, United States. Operations are conducted as a contract development and manufacturing organization (CDMO) within the pharmaceutical sector. Services are centered on the production of various dosage forms, including solids, liquids, and semi-solids. Support is provided to clients for formulation development, scale-up, and commercial manufacturing, with a focus on regulatory compliance and quality standards.
Pharmaceutics International's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Pharmaceutics International offers Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing.
Pharmaceutics International has 5 investors. Key investors include Jabil, PharmaScience, Signet Healthcare Partners, Athyrium Capital Management, and Hildred.